Clinical Trial Results:
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP)
Summary
|
|
EudraCT number |
2020-006082-11 |
Trial protocol |
GR DE HU BG PL RO |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 May 2023
|
First version publication date |
20 May 2023
|
Other versions |
|
Summary report(s) |
Invivyd Inc._ADG20-TRMT-001_Clinical Study Report Synopsis_Version 1.0_18April2023 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.